BeOne Medicines
ONC
#621
Rank
$38.95 B
Marketcap
$352.00
Share price
1.62%
Change (1 day)
57.91%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Market capitalization of BeOne Medicines (ONC)

Market cap: $38.95 Billion USD

As of February 2026 BeOne Medicines has a market cap of $38.95 Billion USD. This makes BeOne Medicines the world's 621th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BeOne Medicines from 2016 to 2026

End of year Market Cap

Year Marketcap Change
2026$38.95 B12.68%
2025$34.56 B68.79%
2024$20.48 B3.89%
2023$19.71 B-22.49%
2022$25.43 B-8.49%
2021$27.79 B17.42%
2020$23.66 B131.65%
2019$10.21 B22.26%
2018$8.35 B87.79%
2017$4.45 B269.44%
2016$1.20 B

End of Day market cap according to different sources

On Feb 4th, 2026 the market cap of BeOne Medicines was reported to be:

$38.95 Billion USD
by Nasdaq info icon info icon
$38.95 Billion USD
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
OPKO Health
OPK
$0.99 B-97.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
$20.9 M-99.95%๐Ÿ‡บ๐Ÿ‡ธ USA